Yue Weng

Oct 13, 2023 | bmccancer.biomedcentral.com | Xi ZHOU |Yue Weng |Nan Zhang |Tiantian Jiang |Qian Dong |Xiaoqiong Tang | +1 more

We have found that DBil, TBil, PLT and Glu were independent influencing factors of anthracycline-induced subclinical cardiotoxicity (AISC) in the acute leukemia patients. Bilirubin may be a protective factor for the development of AISC. Conversely, platelets may be a contributing factor to the development of AISC. The dynamic changes in platelets could better predict AISC in the acute leukemia patients. In addition, PLT and NT-proBNP combined use provided an elevated prognostic value.